All Pharma News
Without Pfizer appeal, Daiichi closes long-running ADC patent with $47M win

Without Pfizer appeal, Daiichi closes long-running ADC patent with $47M win
FIERCE PHARMA
28 Jun 2024
Share Share
Arbitration Dispute Between Daiichi Sankyo and Seagen Ends

Arbitration Dispute Between Daiichi Sankyo and Seagen Ends
BUSINESSWIRE
28 Jun 2024
Share Share
US FDA declines to approve Merck-Daiichi`s `guided missile` cancer drug

US FDA declines to approve Merck-Daiichi`s `guided missile` cancer drug
REUTERS
28 Jun 2024
Share Share
FDA rejects Merck`s first ADC in Daiichi partnership

FDA rejects Merck`s first ADC in Daiichi partnership
Angus Liu FIERCE PHARMA
27 Jun 2024
Share Share
Patritumab Deruxtecan BLA Submission Receives Complete Response Letter From FDA

Patritumab Deruxtecan BLA Submission Receives Complete Response Letter From FDA
BUSINESSWIRE
26 Jun 2024
Share Share
Daiichi Sankyo’s Ezharmia Receives Japanese Approval For T-Cell Lymphoma

Daiichi Sankyo’s Ezharmia Receives Japanese Approval For T-Cell Lymphoma
PHARMABIZ
25 Jun 2024
Share Share
Mika Collaborates with AstraZeneca and Daiichi for Breast Cancer Treatment

Mika Collaborates with AstraZeneca and Daiichi for Breast Cancer Treatment
GLOBENEWSWIRE
18 Jun 2024
Share Share
Bempedoic Acid Cut CVD Risk Across Patient Groups Per CLEAR Outcomes

Bempedoic Acid Cut CVD Risk Across Patient Groups Per CLEAR Outcomes
BUSINESSWIRE
29 May 2024
Share Share
RevolKa enters master service agreement with Daiichi Sankyo

RevolKa enters master service agreement with Daiichi Sankyo
PHARMABIZ
29 May 2024
Share Share
RevolKa Signs Master Service Agreement with Daiichi Sankyo

RevolKa Signs Master Service Agreement with Daiichi Sankyo
CONTRACT PHARMA
28 May 2024
Share Share